Sanofi Agrees To Pay Refund For Unused Dengvaxia Vials, Malacañang Want Full Refund
Ringo | On 16, Jan 2018
Sanofi Pasteur agreed to refund the P1.4 billion-worth of unused Dengvaxia vials.
The Philippine public uproar continues after Sanofi announced that instead of giving protection, Dengvaxia may pose a more serious threat to those people who have not been communicated with Dengue.
“Sanofi Pasteur has responded positively to the Philippine Department of Health’s request that we provide reimbursement for the doses of Dengvaxia that were not used by the government in the public vaccination program,” the Sanofi said.
However, Presidential Spokesperson Harry Roque said the position of the DOH is to have a full refund, which is worth P3.5 billion.
“We welcome that refund but the position of the Department of Health (DOH) is for a full refund,” Roque said. “Nonetheless, we view this latest step of the pharmaceutical company as a step in the right direction.”
Roque clarified that the request for refund will not mean that the government will go easy on them.
“We highlight that the refund will in no way affect ongoing investigations which will ultimately determine whether or not there is criminal culpability on the part of Sanofi,” Roque said.
During the first week of January, the Philippine Food and Drug Administration (FDA) fined Sanofi for the controversial registration of the drug.